Nakamura Miho, Nakamura Hidetoshi, Minematsu Naoto, Chubachi Shotaro, Miyazaki Masaki, Yoshida Shuichi, Tsuduki Keishi, Shirahata Toru, Mashimo Shuko, Takahashi Saeko, Nakajima Takahiro, Tateno Hiroki, Fujishima Seitaro, Betsuyaku Tomoko
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine , Tokyo , Japan .
Biomarkers. 2014 Aug;19(5):368-77. doi: 10.3109/1354750X.2014.915342. Epub 2014 May 19.
Chronic obstructive pulmonary disease (COPD) develops only in smoking-sensitive smokers and manifests heterogeneous phenotypes, including emphysema and non-emphysema types. We aimed to identify biomarkers related to the smoking-sensitivity and phenotypes of COPD. Among 240 smokers suggestive of COPD, we studied on four groups defined by % forced expiratory volume in one second (FEV1) and computed tomography-based pulmonary emphysema. Plasma concentrations of 33 inflammatory markers were measured in four groups as well as Non-smokers using multiplex protein arrays. IL-5, IL-7 and IL-13 were identified to be associated with smoking sensitivity and IL-6 and IL-10 were candidate biomarkers for airway-lesion dominant COPD.
慢性阻塞性肺疾病(COPD)仅在对吸烟敏感的吸烟者中发生,并表现出异质性表型,包括肺气肿型和非肺气肿型。我们旨在确定与COPD的吸烟敏感性和表型相关的生物标志物。在240名疑似患有COPD的吸烟者中,我们根据一秒用力呼气容积(FEV1)百分比和基于计算机断层扫描的肺气肿情况将其分为四组进行研究。使用多重蛋白阵列测量了这四组以及非吸烟者中33种炎症标志物的血浆浓度。白细胞介素-5(IL-5)、白细胞介素-7(IL-7)和白细胞介素-13(IL-13)被确定与吸烟敏感性相关,而白细胞介素-6(IL-6)和白细胞介素-10(IL-10)是气道病变为主型COPD的候选生物标志物。